Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Neurologia | EligiMed
Ensayos clinicos
690 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Comparing the Efficacy, Safety, and Tolerability of Sumanirole Versus Placebo or Ropinirole in Patients With Early Parkinson's Disease.
INTERVENTIONAL
Inicio: 1 de dic de 2001
ID: NCT00036218
Completado
Fase 3
ClinicalTrials.gov
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
INTERVENTIONAL
Inicio: 14 de nov de 2016
ID: NCT02955355
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Fixed Dose-Ranging Study to Assess the Safety, Tolerability, and Efficacy of Topiramate Oral Liquid and Sprinkle Formulations as an Adjunct to Concurrent Anticonvulsant Therapy for Infants (1-24 Months of Age) With Refractory Partial-Onset Seizures
INTERVENTIONAL
Inicio: 1 de may de 2005
ID: NCT00113815
Completado
ClinicalTrials.gov
An International Multicenter Clustered Randomized Controlled Trial to imProve Treatment With AntiCoagulanTs in Patients With Atrial Fibrillation.
INTERVENTIONAL
Inicio: 1 de jun de 2014
ID: NCT02082548
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
INTERVENTIONAL
Inicio: 23 de nov de 2023
ID: NCT06103864
Completado
ClinicalTrials.gov
Trial Clínico. Utilidad Del Telemonitoreo en Pacientes Con IC Como Medio de Apoyo Para la autogestión de la Enfermedad
INTERVENTIONAL
Inicio: 1 de ago de 2018
ID: NCT04071093
Completado
ClinicalTrials.gov
An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials
OBSERVATIONAL
Inicio: 1 de ago de 2008
ID: NCT00734591
Reclutando
ClinicalTrials.gov
Study of the Role of Genetic Modifiers in Hemoglobinopathies
OBSERVATIONAL
Inicio: 1 de oct de 2022
ID: NCT05799118
Completado
Fase 3
ClinicalTrials.gov
A 78 Week Open Label Extension to Trials Assessing the Safety and Efficacy of BI 1356 (5 mg) as Monotherapy or in Combination With Other Antidiabetic Medications in Type 2 Diabetic Patients.
INTERVENTIONAL
Inicio: 1 de ago de 2008
ID: NCT00736099
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Variable Treatment Duration Study Evaluating the Efficacy and Safety of Siponimod (BAF312) in Patients With Secondary Progressive Multiple Sclerosis Followed by Extended Treatment With Open-label BAF312.
INTERVENTIONAL
Inicio: 20 de dic de 2012
ID: NCT01665144
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-Label, Active-Controlled Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Standard of Care
INTERVENTIONAL
Inicio: 8 de oct de 2024
ID: NCT06630299
Completado
Fase 3
ClinicalTrials.gov
An Open-Label Extension Of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00791492
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin Angiotensin Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND)
INTERVENTIONAL
Inicio: 24 de abr de 2019
ID: NCT03888066
Completado
ClinicalTrials.gov
Decision Making Under Uncertainty in MS Care: an Innovative Educational Intervention Applying Concepts From Neuroeconomics
INTERVENTIONAL
Inicio: 22 de mar de 2017
ID: NCT03134794
Activo, no recluta
ClinicalTrials.gov
NeVa International, MulTi-center, Retrospective cOmparative Stent Retriever Study
OBSERVATIONAL
Inicio: 15 de jun de 2025
ID: NCT06964724
Completado
ClinicalTrials.gov
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
OBSERVATIONAL
Inicio: 21 de feb de 2013
ID: NCT01729455
Terminado
Fase 3
ClinicalTrials.gov
Multinational, Randomized, Double-Blind, Double Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 10 Days Penicillin V 13.3 mg/kg Tid in Children 6 Months to Less Than 13 Years With Streptococcus Pyogenes Tonsillitis/Pharyngitis
INTERVENTIONAL
Inicio: 1 de mar de 2006
ID: NCT00315042
Terminado
Fase 1
ClinicalTrials.gov
A Phase 1, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily Oral Administration of AV-412 in Patients With Refractory or Relapsed Solid Tumor Malignancies
INTERVENTIONAL
Inicio: 1 de oct de 2006
ID: NCT00381654
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-3)
INTERVENTIONAL
Inicio: 2 de dic de 2025
ID: NCT06937229
Completado
Fase 4
ClinicalTrials.gov
Randomised, Openlabel Study Evaluating Efficacy and Safety of Maraviroc as a Switch for Either NRTI or PI/r in HIV-1 Infected Individuals With Stable, Well-Controlled Plasma HIV-RNA While Taking Their First N(t)RTI + PI/r Regimen of cART
INTERVENTIONAL
Inicio: 1 de ago de 2011
ID: NCT01384682
Anterior
1
...
32
33
34
35
Siguiente
Filtros